One-Year Follow-up Safety Study in Subjects Previously Implanted With VC-01™
NCT02939118 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51
Last updated 2024-04-23
Summary
The purpose of this trial is to evaluate the long-term safety in subjects previously implanted with VC-01™ combination product.
Conditions
- Type 1 Diabetes Mellitus
Sponsors & Collaborators
-
ViaCyte
lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-11-07
- Primary Completion
- 2024-02-08
- Completion
- 2024-02-08
More Related Trials
-
An Open-Label, FIH Study Evaluating the Safety and Tolerability of VCTX210A Combination Product in Subjects With T1D
NCT05210530 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Feasibility of an Insulin Sensitivity-Informed Bolus Calculator in Type 1 Diabetes
NCT03709108 ·Status: COMPLETED ·Phase: NA
-
Islet Transplant in Patients With Type I Diabetes
NCT03698396 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Safety of ENC-201-CED ENCRT
NCT06408311 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes
NCT05791201 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Longevity of Multi-Slitted Catheter With Lantern Technology
NCT03819634 ·Status: COMPLETED ·Phase: NA
-
A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation
NCT03513939 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes
NCT02463097 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Extended Wear Infusion Set (EWIS) in Patients With Type 1 Diabetes
NCT04113694 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics (PK)/ Pharmacodynamics (PD) of an Extended Wear Infusion Set for Continuous Subcutaneous Insulin Infusion (CSII) in Type 1 Diabetes Mellitus (T1DM) Patients ("PEXIS")
NCT04398030 ·Status: COMPLETED ·Phase: NA
-
A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes
NCT07126873 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Safety of Insulin Detemir for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus
NCT01709929 ·Status: COMPLETED ·Phase: PHASE3
-
Extended Wear of a Steel and a Teflon Insulin Infusion Set
NCT03683368 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of 7-day Wear Infusion Set vs. Control Infusion Set.
NCT04208282 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus
NCT06964087 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluation of Extended Infusion Set Wear Using Medtronic Extended Wear Sof-set Infusion Set
NCT02687256 ·Status: COMPLETED ·Phase: PHASE1
-
OPT101 in Type 1 Diabetes Patients
NCT05428943 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
NCT04786262 ·Status: RECRUITING ·Phase: PHASE3
-
Accuracy of a Continuous Ketone Monitoring (CKM) System in Individuals With Type 1 Diabetes on Insulin Pump Therapy.
NCT06420518 ·Status: COMPLETED
-
Prevention of Severe Hypoglycemia in Type 1 Diabetes
NCT00360984 ·Status: COMPLETED ·Phase: PHASE4
-
"FEXIS": (Feasibility of an Extended Wear CSII Set in Participants With T1DM)
NCT04503564 ·Status: COMPLETED ·Phase: NA
-
Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes
NCT06273124 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes
NCT07325461 ·Status: RECRUITING ·Phase: NA
-
A Pilot Study to Assess the Safety, PK and PD of Insulin Injected Via MicronJet or Conventional Needle
NCT00602914 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
21 Day Comparison of Continuous Insulin Infusion Using HDV Insulin to Standard Insulin in Type 1 Diabetes Mellitus
NCT03156361 ·Status: COMPLETED ·Phase: PHASE2